Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vitamin C and oxycodone for prevention of CRPS after distal radius fracture
IRCT20241230064213N1Phase 3Completed
- Sponsor
- Iran University of Medical Sciences
- Start
- Aug 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of ascorbic acid, oxycodone and Placebo-COD Research Private Ltd in complex regional pain syndrome (CRPS) (3 arms), sponsored by Iran University of Medical Sciences. Primary endpoints: Pain intensity at week 8, Hand function at week 8 and 1 more. Started Aug 2024; status: completed.
02
Drugs
ascorbic acidoxycodonePlacebo-COD Research Private Ltd
03
Conditions
complex regional pain syndrome (CRPS)
Beyond the preview
Go deeper on IRCT20241230064213N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20241230064213N1.